Cure
Overview
The United States leads in scientific quality and commercial depth. China leads in speed, scale, and cost. Five analyses map both sides of the divide.
The U.S. leads in science. China leads in speed. Who wins the race to cures?
The Cure Innovation Index Cure U.S.-China Biotech Competitiveness Scorecard maps the dividing line between American scientific excellence and China's rapidly scaling development engine and what's at stake for the next decade of medicine.
Drawing on an expert survey of 117 senior industry and academic leaders, three bibliometric analyses, and a clinical trial infrastructure study, the Scorecard reveals where the US holds durable advantages, where China is pulling ahead, and the imperatives that will determine whether the US lead holds.
Download the full report to explore the data.
